{
  "ticker": "GOSS",
  "company_name": "Gossamer Bio, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03956862",
      "title": "GB001 in Adult Participants With Chronic Rhinosinusitis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP), Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)",
      "start_date": "2019-05-16",
      "completion_date": "2020-08-05",
      "enrollment": 0,
      "sponsor": "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc."
    },
    {
      "nct_id": "NCT05934526",
      "title": "Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Pulmonary Arterial Hypertension",
      "start_date": "2023-12-28",
      "completion_date": "2025-12-22",
      "enrollment": 0,
      "sponsor": "GB002, Inc."
    },
    {
      "nct_id": "NCT04816604",
      "title": "Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Pulmonary Arterial Hypertension",
      "start_date": "2021-04-05",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc."
    },
    {
      "nct_id": "NCT03926793",
      "title": "Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Pulmonary Arterial Hypertension",
      "start_date": "2020-02-04",
      "completion_date": "2021-05-05",
      "enrollment": 0,
      "sponsor": "GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc."
    },
    {
      "nct_id": "NCT03473236",
      "title": "Phase 1A Safety Trial of Inhaled PK10571 (GB002)",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Safety Issues",
      "start_date": "2017-09-06",
      "completion_date": "2018-12-03",
      "enrollment": 0,
      "sponsor": "GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc."
    },
    {
      "nct_id": "NCT04556383",
      "title": "A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Ulcerative Colitis",
      "start_date": "2020-10-19",
      "completion_date": "2022-06-01",
      "enrollment": 0,
      "sponsor": "GB004, Inc."
    },
    {
      "nct_id": "NCT05242146",
      "title": "GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "CNS Lymphoma",
      "start_date": "2022-05-24",
      "completion_date": "2023-05-11",
      "enrollment": 0,
      "sponsor": "GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc."
    },
    {
      "nct_id": "NCT04060342",
      "title": "GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Triple Negative Breast Cancer, Castration-resistant Prostate Cancer, Microsatellite Stable Colorectal Cancer, Non-small Cell Lung Cancer, Small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma, Renal Cell Carcinoma, Hepatocellular Carcinoma",
      "start_date": "2019-08-13",
      "completion_date": "2022-04-11",
      "enrollment": 0,
      "sponsor": "GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc."
    },
    {
      "nct_id": "NCT04456998",
      "title": "GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Pulmonary Artery Hypertension",
      "start_date": "2020-11-12",
      "completion_date": "2022-11-01",
      "enrollment": 0,
      "sponsor": "GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc."
    },
    {
      "nct_id": "NCT07181382",
      "title": "Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Pulmonary Hypertension Associated With Interstitial Lung Disease",
      "start_date": "2025-12",
      "completion_date": "2028-12",
      "enrollment": 0,
      "sponsor": "GB002, Inc."
    }
  ],
  "summary": {
    "total_trials": 13,
    "by_phase": {
      "PHASE2": 5,
      "PHASE3": 3,
      "PHASE1": 5
    },
    "by_status": {
      "COMPLETED": 7,
      "ACTIVE_NOT_RECRUITING": 2,
      "TERMINATED": 3,
      "RECRUITING": 1
    },
    "active_trials": 3,
    "completed_trials": 7,
    "conditions": [
      "Asthma",
      "CNS Lymphoma",
      "Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP), Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)",
      "Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Triple Negative Breast Cancer, Castration-resistant Prostate Cancer, Microsatellite Stable Colorectal Cancer, Non-small Cell Lung Cancer, Small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma, Renal Cell Carcinoma, Hepatocellular Carcinoma",
      "Pulmonary Arterial Hypertension",
      "Pulmonary Artery Hypertension",
      "Pulmonary Hypertension Associated With Interstitial Lung Disease",
      "Safety Issues",
      "Ulcerative Colitis"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:33:12.992879",
    "search_query": "Gossamer Bio, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Gossamer+Bio,+Inc."
  }
}